Stephen C Dreskin Selected Research

Stephen C Dreskin Research Topics

Disease

10	Hypersensitivity (Allergy) 02/2023 - 03/2008
9	Peanut Hypersensitivity (Peanut Allergy) 12/2019 - 12/2010
5	Chronic Urticaria 03/2024 - 05/2003
5	Anaphylaxis (Anaphylactic Shock) 01/2019 - 05/2011
4	Food Hypersensitivity (Food Allergy) 01/2021 - 02/2006
4	Asthma (Bronchial Asthma) 01/2016 - 07/2006
4	Inflammation (Inflammations) 04/2007 - 07/2006
3	Immediate Hypersensitivity 12/2013 - 12/2007
3	Urticaria (Hives) 03/2008 - 05/2004
3	Eosinophilia 07/2006 - 07/2006
2	Leukemia 05/2015 - 03/2003
2	Human Influenza (Influenza) 12/2013 - 02/2013
2	Allergic Rhinitis 05/2006 - 10/2002
1	COVID-19 01/2021
1	Infections 01/2021
1	Burns 01/2014
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2014
1	Exanthema (Rash) 01/2014
1	Urinary Tract Infections (Urinary Tract Infection) 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 08/2011
1	Japanese Encephalitis 09/2008
1	Diphtheria 09/2008
1	Tetanus 09/2008
1	Whooping Cough (Pertussis) 09/2008
1	Seasonal Allergic Rhinitis (Hay Fever) 03/2008
1	Hyperplasia 07/2006
1	Pneumonia (Pneumonitis) 07/2006
1	Rhinorrhea 05/2006
1	Chronic Disease (Chronic Diseases) 10/2005

Drug/Important Bio-Agent (IBA)

12	Immunoglobulin E (IgE)IBA 03/2024 - 10/2005
11	AllergensIBA 02/2023 - 10/2002
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2002
5	VaccinesIBA 01/2021 - 09/2008
5	CytokinesIBA 04/2007 - 10/2002
4	hypoxanthine arabinoside (ara-H)IBA 12/2019 - 03/2013
4	thymoquinoneIBA 04/2007 - 07/2006
3	Histamine Antagonists (Antihistamines)IBA 03/2024 - 05/2004
3	AntibodiesIBA 01/2021 - 10/2005
3	EpitopesIBA 12/2019 - 05/2015
2	Omalizumab (Xolair)FDA Link 03/2024 - 01/2014
2	Peptides (Polypeptides)IBA 02/2023 - 05/2015
2	AntigensIBA 01/2021 - 07/2006
2	Influenza Vaccines (Influenza Vaccine)FDA Link 02/2013 - 12/2007
2	Interleukin-5 (Interleukin 5)IBA 03/2008 - 10/2002
2	Prostaglandin D2IBA 07/2006 - 05/2006
2	Volatile Oils (Essential Oils)IBA 07/2006 - 07/2006
2	IgE Receptors (Fc epsilon RI)IBA 06/2006 - 03/2003
1	Biomarkers (Surrogate Marker)IBA 03/2024
1	plant vicilin proteinIBA 02/2023
1	AlbuminsIBA 01/2021
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2021
1	hydroxide ionIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2017
1	ImmunosorbentsIBA 01/2014
1	EnzymesIBA 01/2014
1	Cephalexin (Cefalexin)FDA LinkGeneric 01/2014
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2014
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2013
1	Immunoglobulins (Immunoglobulin)IBA 12/2010
1	GelatinIBA 09/2008
1	Interleukin-4 (Interleukin 4)IBA 03/2008
1	Thimerosal (Thiomersal)IBA 12/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007
1	Arachidonic Acid (Vitamin F)IBA 07/2006
1	ProstaglandinsIBA 07/2006
1	Cyclooxygenase 1IBA 07/2006
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2006
1	LeukotrienesIBA 07/2006
1	OvalbuminIBA 07/2006
1	Immunoglobulin G (IgG)IBA 06/2006
1	AutoantibodiesIBA 10/2005
1	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2005
1	anti-IgE antibodiesIBA 10/2005
1	SteroidsIBA 05/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2004
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2003
1	Messenger RNA (mRNA)IBA 10/2002

Therapy/Procedure

5	Therapeutics 01/2014 - 10/2005
2	Immunotherapy 12/2019 - 01/2017
2	Intraperitoneal Injections 07/2006 - 07/2006
1	Duration of Therapy 01/2014